ג'מסיטאבין אקטביס 1000 מ"ג/בקבוקון Israel - hebraisk - Ministry of Health

ג'מסיטאבין אקטביס 1000 מ"ג/בקבוקון

devries & co. ltd - gemcitabine 1000 mg/vial - powder for solution for infusion - gemcitabine - gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin. gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc). gemcitabine monotherapy can be considered in elderly patients or those with performance status 2. gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy. gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherap

גמסיטאבין טבע  תמיסה מרוכזת Israel - hebraisk - Ministry of Health

גמסיטאבין טבע תמיסה מרוכזת

abic marketing ltd, israel - gemcitabine as hydrochloride - תרכיז להכנת תמיסה לאינפוזיה - gemcitabine as hydrochloride 40 mg/ml - gemcitabine - gemcitabine - gemcitabine teva® concentrate is indicated for the palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer.gemcitabine teva® concentrate is indicated for the treatment of patients with bladder cancer at the invasive stage.breast cancer:gemcitabine teva® concentrate in combination with paclitaxel,is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant /neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated.ovarian cancer:gemcitabine teva® concentrate in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma who have relapsed at least 6 months after platinum-based therapy.

אדריבלסטינה 10 מ"ג PFS Israel - hebraisk - Ministry of Health

אדריבלסטינה 10 מ"ג pfs

pfizer pharmaceuticals israel ltd - doxorubicin hydrochloride 10 mg / 5 ml - solution for injection - doxorubicin - adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, hodgkin's lymphomas, neuroblastomas, wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

אדריבלסטינה 50 מ"ג PFS Israel - hebraisk - Ministry of Health

אדריבלסטינה 50 מ"ג pfs

pfizer pharmaceuticals israel ltd - doxorubicin hydrochloride 50 mg / 25 ml - solution for injection - doxorubicin - adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, hodgkin's and non- hodgkin's lymphomas, neuroblastomas, wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

אוקסלטין 50 מ"ג Israel - hebraisk - Ministry of Health

אוקסלטין 50 מ"ג

perrigo israel agencies ltd - oxaliplatin 50 mg - powder for solution for infusion - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for:- adjuvant treatment of stage iii (duke’s c) colon cancer after complete resection of primary tumour.-treatment of metastatic colorectal cancer.

אוקסלטין 100 מ"ג Israel - hebraisk - Ministry of Health

אוקסלטין 100 מ"ג

perrigo israel agencies ltd - oxaliplatin 100 mg - powder for solution for infusion - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for:- adjuvant treatment of stage iii (duke’s c) colon cancer after complete resection of primary tumour.-treatment of metastatic colorectal cancer.

פוטאקטזול 1 מ"ג Israel - hebraisk - Ministry of Health

פוטאקטזול 1 מ"ג

devries & co. ltd - topotecan hydrochloride 1 mg - powder for concentrate for soution for infusion - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

ריוואסטיגמין אינובמד 1.5 מ"ג Israel - hebraisk - Ministry of Health

ריוואסטיגמין אינובמד 1.5 מ"ג

inovamed ltd - rivastigmine as hydrogen tartrate 1.5 mg - capsules - rivastigmine - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

דסלורטדין אינובמד Israel - hebraisk - Ministry of Health

דסלורטדין אינובמד

inovamed ltd - desloratadine 5 mg - film coated tablets - desloratadine - for the relief of symptoms associated with: allergic rhinitis, urticaria.

 וינורלבין- תרימה 10 מג מל Israel - hebraisk - Ministry of Health

וינורלבין- תרימה 10 מג מל

trima trading (1961), israel - vinorelbine as tartrate - תרכיז להכנת תמיסה לאינפוזיה - vinorelbine as tartrate 10 mg/ml - vinorelbine